Integrative Analysis of Clinical and Bioinformatics Databases to Reveal the Role of Peripheral Innate Immunity in Kawasaki Disease
Table 4
Comparison of the IVIG-responsive and -resistant patients with KD in terms of demographic and clinical variables.
Variable
IVIG-responsive (n = 133)
IVIG-resistant (n = 18)
P-value
Age (months)
21.9 (13.2, 40.5)
27.95 (16.2, 35.5)
0.918
Male (n, percentage)
86 (64.7%)
13 (72.2%)
0.528
CRP (mg/L)
80 (45.9, 111.0)
121.5 (82.9, 148.2)
0.026
PCT (ng/mL)
0.5 (0.2, 1.2)
1.2 (0.3, 3.1)
0.09
WBC (×109/L)
14.3 (11.5, 19.0)
15.2 (11.8, 26.1)
0.789
NEUT (×109/L)
8.9 (6.5, 11.9)
10.7 (8.3, 16.2)
0.325
LYM (×109/L)
3.7 (2.6, 6.0)
2.9 (0.9, 6.5)
0.03
MONO (×109/L)
0.9 (0.6, 1.3)
1.0 (0.5, 1.5)
0.945
PLT (×109/L)
383 (310.5, 493.5)
372.5 (229.7, 459.7)
0.308
NLR
2.5 (1.5, 3.5)
3.7 (1.5, 13.1)
0.012
Note. CRP, C-reactive protein; PCT, procalcitonin; WBC, white blood cells; NEUT, neutrophil; LYM, lymphocyte; MONO, monocytes; PLT, platelet; NLR, neutrophil/lymphocyte ratio. The data are presented as Median (interquartile spacing) or number (%).
